...
首页> 外文期刊>Journal of Surgical Case Reports >Radiofrequency ablation coupled with Roux-en-Y gastric bypass: a treatment option for morbidly obese patients with Barrett's esophagus
【24h】

Radiofrequency ablation coupled with Roux-en-Y gastric bypass: a treatment option for morbidly obese patients with Barrett's esophagus

机译:射频消融结合Roux-en-Y胃旁路术:病态肥胖Barrett食管患者的治疗选择

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Barrett's esophagus (BE) is a premalignant condition that is associated with the development of esophageal adenocarcinoma. Risk factors that have been associated with the development of BE include male gender, Caucasian race, chronic gastroesophageal reflux disease, smoking, age 50 and obesity. The current management of BE is dependent on underlying pathological changes and treatment can range from surveillance endoscopy with daily proton pump inhibitor (PPI) therapy in the setting of intestinal metaplasia or low-grade dysplasia (LGD) to radiofrequency ablation (RFA), endoscopic mucosal resection or surgical resection in the setting of high-grade dysplasia. We report the case of a morbidly obese patient who was found to have long-segment BE with LGD during preoperative work-up for weight loss surgery with Roux-en-Y gastric bypass (RYGBP). The patient underwent successful RFA for the treatment of her BE before and after her RYGBP procedure. At 5-year follow-up, there was minimal progression of BE after treatment.
机译:巴雷特食管(BE)是一种恶性前病,与食管腺癌的发展有关。与BE发展有关的危险因素包括男性,白种人,慢性胃食管反流病,吸烟,年龄> 50岁和肥胖。 BE的当前治疗取决于潜在的病理变化,治疗范围从在肠上皮化生或低度不典型增生(LGD)的情况下采用每日质子泵抑制剂(PPI)监测内镜到射频消融(RFA),内镜黏膜高度不典型增生的手术切除或手术切除。我们报告了一名病态肥胖患者的病例,该患者在接受Roux-en-Y胃旁路术(RYGBP)进行的减肥手术的术前检查中被发现患有LGD的长段BE。在RYGBP手术前后,患者均接受了成功的RFA治疗以治疗BE。在5年的随访中,治疗后BE的进展很小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号